Anyone here want to speculate that if Downer needs to raise money through a rights issue/placement/share purchase plan what would be the price and what the amount would be?
Usually these will be done at a 15-20% market price discount from my experience. I have to admit that the last placement I took up was Reed Resources (RDR) so maybe I am comparing a spec stock to Downer would be unfair.
The provision for the Railcorp deal seems to be $350million by the time the saga ends (I am expecting more write-downs in the next 6-12 months since management has proven to be incompetent). There may be other smaller write-downs on the cards? I think Downer would need to raise in the range of $400-$450million.
Downer debt is also very very high compared to the industry and its equity. Then again the share price was $8+ not too long ago so the equity side has more than halved in value.
Anyone think that this could lead to a takeover by a predator taking advantage of DOW weakness?
I am thinking to buy some DOW for the long term but only after they clarify the capital raising issue that seems to be in the media of late.
- Forums
- ASX - By Stock
- DOW
- capital raising price and amount
capital raising price and amount
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DOW (ASX) to my watchlist
|
|||||
Last
$4.93 |
Change
0.070(1.44%) |
Mkt cap ! $3.310B |
Open | High | Low | Value | Volume |
$4.92 | $4.96 | $4.88 | $3.670M | 746.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17538 | $4.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.93 | 3755 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1935 | 4.910 |
1 | 919 | 4.900 |
2 | 5705 | 4.890 |
5 | 17152 | 4.880 |
1 | 919 | 4.870 |
Price($) | Vol. | No. |
---|---|---|
4.930 | 325 | 2 |
4.940 | 8088 | 3 |
4.950 | 9640 | 1 |
4.970 | 6064 | 1 |
4.980 | 3100 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
DOW (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online